Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0022 Transporter Info
Gene Name	SLC15A2
Transporter Name	Peptide transporter 2
Gene ID	6565
UniProt ID	Q16348

Post-Translational Modification of This DT
Overview of SLC15A2 Modification Sites with Functional and Structural Information
Sequence	M N P F Q K N E S K E T L F S P V S I E E V P P R P P S P P K K P S P T I C G S N Y P L S I A F I V V N E F C E R F S Y Y G M K A V L I L Y F L Y F L H W N E D T S T S I Y H A F S S L C Y F T P I L G A A I A D S W L G K F K T I I Y L S L V Y V L G H V I K S L G A L P I L G G Q V V H T V L S L I G L S L I A L G T G G I K P C V A A F G G D Q F E E K H A E E R T R Y F S V F Y L S I N A G S L I S T F I T P M L R G D V Q C F G E D C Y A L A F G V P G L L M V I A L V V F A M G S K I Y N K P P P E G N I V A Q V F K C I W F A I S N R F K N R S G D I P K R Q H W L D W A A E K Y P K Q L I M D V K A L T R V L F L Y I P L P M F W A L L D Q Q G S R W T L Q A I R M N R N L G F F V L Q P D Q M Q V L N P L L V L I F I P L F D F V I Y R L V S K C G I N F S S L R K M A V G M I L A C L A F A V A A A V E I K I N E M A P A Q P G P Q E V F L Q V L N L A D D E V K V T V V G N E N N S L L I E S I K S F Q K T P H Y S K L H L K T K S Q D F H F H L K Y H N L S L Y T E H S V Q E K N W Y S L V I R E D G N S I S S M M V K D T E S R T T N G M T T V R F V N T L H K D V N I S L S T D T S L N V G E D Y G V S A Y R T V Q R G E Y P A V H C R T E D K N F S L N L G L L D F G A A Y L F V I T N N T N Q G L Q A W K I E D I P A N K M S I A W Q L P Q Y A L V T A G E V M F S V T G L E F S Y S Q A P S S M K S V L Q A A W L L T I A V G N I I V L V V A Q F S G L V Q W A E F I L F S C L L L V I C L I F S I M G Y Y Y V P V K T E D M R G P A D K H I P H I Q G N M I K L E T K K T K L
PTM type	X-Acetylation X-N-glycosylation X-Phosphorylation X: Amino Acid

Acetylation
Lysine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC15A2			[1]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	10
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SLC15A2 Lysine 10 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC15A2			[2]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	31
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SLC15A2 Lysine 31 has the potential to affect its expression or activity.
N-glycosylation
Asparagine	7 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC15A2			[3]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	7
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC15A2 Asparagine 7 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC15A2			[3]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	269
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC15A2 Asparagine 269 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC15A2			[3]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	373
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC15A2 Asparagine 373 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC15A2			[3]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	435
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC15A2 Asparagine 435 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC15A2			[3]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	472
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC15A2 Asparagine 472 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC15A2			[3]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	528
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC15A2 Asparagine 528 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC15A2			[3]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	567
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC15A2 Asparagine 567 has the potential to affect its expression or activity.
Phosphorylation
Serine	4 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC15A2			[4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	18
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC15A2 Serine 18 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC15A2			[4] , [5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	28
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC15A2 Serine 28 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC15A2			[6]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	376
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC15A2 Serine 376 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC15A2			[7]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	508
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC15A2 Serine 508 has the potential to affect its expression or activity.
Threonine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC15A2			[7]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	510
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC15A2 Threonine 510 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC15A2			[7]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	522
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC15A2 Threonine 522 has the potential to affect its expression or activity.
Tyrosine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC15A2			[8]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	60
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC15A2 Tyrosine 60 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC15A2			[8]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	61
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC15A2 Tyrosine 61 has the potential to affect its expression or activity.

References
1	The helix-coil transition in polypeptides: a microscopic approach. II. Biopolymers. 1995 Jan;35(1):75-84.
2	Hydrogen exchange studies of the Arc repressor: evidence for a monomeric folding intermediate. Biopolymers. 1995 Feb;35(2):217-26.
3	dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: S15A2_HUMAN)
4	A fast sample processing strategy for large-scale profiling of human urine phosphoproteome by mass spectrometry. Talanta. 2018 Aug 1;185:166-173.
5	Defective sphingosine 1-phosphate receptor 1 (S1P1) phosphorylation exacerbates TH17-mediated autoimmune neuroinflammation. Nat Immunol. 2013 Nov;14(11):1166-72.
6	Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
7	Quantitative phosphoproteomic profiling of human non-small cell lung cancer tumors. J Proteomics. 2013 Oct 8;91:286-96.
8	Phosphoproteomics identifies driver tyrosine kinases in sarcoma cell lines and tumors. Cancer Res. 2012 May 15;72(10):2501-11.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence